Sibrotuzumab
- Generic Name
- Sibrotuzumab
- Drug Type
- Biotech
- Unique Ingredient Identifier
- 552U6E1NIW
Overview
Sibrotuzumab is a humanized monoclonal antibody directed against fibroblast activation protein (FAP). It is used to treat cancer.
Background
Sibrotuzumab is a humanized monoclonal antibody directed against fibroblast activation protein (FAP). It is used to treat cancer.
Indication
Investigated for use/treatment in cancer/tumors (unspecified), colorectal cancer, and lung cancer.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath